Mark I. Anderson, MD

Mark I. Anderson, MD, is a board-certified urologist who treats the full spectrum of urologic conditions. He has specialized training in microsurgery and vasectomy reversals. After 21 years in the U.S. Army, Dr. Anderson retired from service, where he spent 10 years teaching at Madigan Army Medical Center. An advocate of making medical decisions a collaborative effort, he favors keeping patients informed to empower them to be an active part of their health care. 

The conditions  Dr. Anderson treats include:

• Kidney stones
• Prostate health
• Fertility-related conditions
• Male health (erectile dysfunction/bladder dysfunction)

The procedures Dr. Anderson performs include:

• Stone removal from urinary tract 
• Non-invasive treatment of kidney stones through electroshock wave lithotripsy (ESWL)
• Transurethral resection of the prostate (TURP) & Greenlight™ Laser TURP
• Vasectomy
• Microsurgery, including vasectomy reversal and varicocele ligation
• Bladder tumor resection
• Prostate biopsy

• American Urological Association
• Western Section of the American Urological Association
• Society of Government Service Urologists

Vasectomy Reversal in an Open Access System: A 14-year Experience, Alexandria M. Hertz MD, Mark I. Anderson MD, Andrew W. Stamm MD, Karen C. Baker MD; presented at the Society of Government Service Urologists 66th James C. Kimbrough Urological Seminar, Kona, HI, January 2019.

Solitary Fibrous Tumor of the Renal Vein Presenting as Renal Artery Aneurysm: A Case Report, Alexandria M. Hertz MD, Jason T. Perry MD, Charles A. Kitley MD, Mark I. Anderson MD; presented at the Western Section American Urological Association Annual Meeting, Vancouver, BC, August 2017.

Retrospective Review of the Utility of CT Urography in the setting of initial Asymptomatic Microscopic Hematuria, Karmon M. Janssen, DO, Mark I. Anderson, MD, presented at the Western Section American Urological Association Annual Meeting, Kauai, HI, October 2016.

Filariasis Orchitis - Differential for Acute Scrotum Pathology, Karmon M Janssen D.O., Mark I. Anderson, MD; presented at the Western Section American Urological Association Annual Meeting, October 2016, Kauai, HI.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer, Associate Investigator, September 2013 – closed 2016.

CALGB 70807, The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance, Associate Investigator, August 2013 – closed 2015.

RTOG 0534, A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy, Associate Investigator, September 2013 – closed 2015.

A Randomized Controlled Study on Nutrition Counseling for Kidney Stone Patients Reveals Abysmal Compliance in an Equal Access Fully Subsidized Healthcare System. Poster presented at the Western Section of the American Urological Association 90th Annual Meeting, Maui, HI, October 2014.

A Randomized, Double-Blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men with Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate Cancer, Associate Investigator, October 2013 – closed 2014.

Nutrition Education Practices for Patients with Renal Stones, Associate Investigator, February 2012 – October 2013.

A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage, Principal Investigator, April 2012 – Dec 2012.

Clinical Pathway Hastens Completion of Hematuria Referrals. Poster presentation at the Western Section of the American Urological Association 87th Annual Meeting, Vancouver, BC, August 2011.

Oral Ketoconazole for Prevention of Postoperative Penile Erection, a Prospective, Randomized, Double Blind Trial. B. DeCastro, J. Pugliese, M. Anderson, J. Walter, L. McMann, A. Peterson; presented at the 54th Annual James C. Kimbrough Urological Seminar, Houston, TX, January 2007.

Genitourinary Injuries in Modern Warfare. M. Anderson; presented at the 53rd Annual James C. Kimbrough Urological Seminar, Savannah, GA, January 2006.

The Epidemiology of Nephrolithiasis in Military Personnel Returning from Operation Iraqi Freedom. J. Pugliese, M. Anderson, K. Baker; presented at the 53rd Annual James C. Kimbrough Urological Seminar, Savannah, GA, January 2006.

Rapid Progression of Renal Tumors After Radiofrequency Ablation. M. Anderson, A. Peterson; presented at the 53rd Annual James C. Kimbrough Urological Seminar, Savannah, GA, January 2006.

Prevalence of Human Papilloma Virus in Urethral Swabs of Male Patients Undergoing Testing for Sexually Transmitted Disease. M. Anderson, S. Mahlon, K. Baker; presented at the 52nd Annual James C. Kimbrough Urological Seminar, Honolulu, HI, January 2005; also presented at the AUA Western Section annual meeting, Vancouver, BC, December 2004.

High Dose Corticosteroid Treatment of Hemotympanum in Military Free-Fall Students. S. MacLeod, J. Barrett, M. Anderson; presented at Madigan Research Day, April 2001; won Change in Practice Award.

Pigment Dispersion Syndrome Presenting as Exertional Migraine. M. McMann, M. Anderson, M. Grazko; presented at 26th Annual North American Neuro-opthalmology Society meeting, March 2000.

Retroperitoneal Bronchogenic Cyst Mimicking a Pheochromocytoma. M. Anderson, K. O’Reilly, R. Costabile; The Journal of Urology, Vol. 166, October 2001; presented at the 47th Annual James C. Kimbrough Urological Seminar, San Diego, CA, January 2000.

Combined and Sequential Paclitaxel-based Chemosensitivity in Renal Cell Adenocarcinoma cell lines. J. DeHaven, M. Anderson, A. Kamat, D. Riggs, T. Hogan, D. Lamm; presented at the 1999 Annual Meeting of the American Society of Clinical Oncology.